Robert F Storey Selected Research

Chronic Renal Insufficiency

12/2023	Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum.
1/2019	Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.
9/2013	Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study.
1/2012	Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.
12/2011	Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.
9/2010	Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert F Storey Research Topics

Disease

135	Acute Coronary Syndrome 02/2024 - 09/2002
104	Myocardial Infarction 03/2024 - 11/2007
94	Hemorrhage 05/2024 - 11/2007
74	Thrombosis (Thrombus) 03/2024 - 03/2005
60	Stroke (Strokes) 10/2023 - 09/2009
36	ST Elevation Myocardial Infarction 03/2024 - 11/2007
34	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 11/2007
14	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 08/2010
14	Diabetes Mellitus 12/2023 - 10/2010
14	Atrial Fibrillation 12/2023 - 09/2014
11	Inflammation (Inflammations) 12/2023 - 04/2010
10	Heart Failure 02/2024 - 12/2011
8	Vascular Diseases (Vascular Disease) 11/2022 - 08/2010
7	Atherosclerosis 01/2023 - 10/2005
7	Dyspnea (Shortness of Breath) 01/2020 - 07/2010
6	Ischemia 03/2024 - 01/2012
6	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2017
6	Chronic Renal Insufficiency 12/2023 - 09/2010
6	Infections 01/2023 - 10/2012
6	Peripheral Arterial Disease 06/2021 - 06/2015
5	Heart Diseases (Heart Disease) 12/2023 - 09/2002
5	Coronary Disease (Coronary Heart Disease) 01/2021 - 04/2016
5	Atherosclerotic Plaque (Atheroma) 08/2017 - 04/2010
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2023 - 01/2012
4	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 12/2018
4	Sepsis (Septicemia) 01/2023 - 01/2014
3	Body Weight (Weight, Body) 12/2023 - 05/2017
3	Non-ST Elevated Myocardial Infarction 08/2023 - 04/2010
3	Chest Pain (Chest Pains) 01/2022 - 04/2019
3	Ischemic Stroke 06/2021 - 09/2016
3	Cardiac Arrhythmias (Arrythmia) 02/2019 - 10/2012
3	Sudden Death 11/2018 - 10/2012
3	Transient Ischemic Attack 09/2014 - 06/2012
2	Coronary Thrombosis 12/2023 - 01/2018
2	Thrombocytopenia (Thrombopenia) 02/2023 - 01/2022
2	Pathologic Constriction (Stenosis) 01/2023 - 07/2013
2	Necrosis 06/2022 - 08/2015
2	COVID-19 01/2022 - 11/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021 - 01/2021
2	Anemia 01/2021 - 04/2017
2	Endotoxemia 01/2021 - 04/2020

Drug/Important Bio-Agent (IBA)

134	TicagrelorIBA 12/2023 - 11/2007
80	Clopidogrel (Plavix)FDA Link 12/2023 - 09/2002
63	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 11/2007
25	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2010
14	Prasugrel Hydrochloride FDA Link 12/2023 - 06/2010
14	Purinergic P2Y Receptor AntagonistsIBA 12/2023 - 11/2002
12	Growth Differentiation Factor 15IBA 01/2023 - 01/2014
11	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2023 - 01/2016
11	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 07/2010
10	omega-Chloroacetophenone (Mace)IBA 03/2024 - 01/2016
10	AnticoagulantsIBA 01/2024 - 06/2008
10	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2014
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2023 - 06/2008
9	Troponin T (Troponin T1)IBA 01/2023 - 04/2016
8	C-Reactive ProteinIBA 01/2023 - 04/2010
7	vorapaxarIBA 11/2022 - 01/2012
7	Thrombin Receptors (Thrombin Receptor)IBA 11/2022 - 01/2012
7	TroponinIBA 07/2022 - 05/2016
7	FibrinIBA 01/2021 - 04/2010
7	Cystatin CIBA 12/2019 - 01/2012
6	Vitamin K FDA Link 01/2024 - 04/2016
6	Cytochrome P-450 CYP2C19IBA 01/2021 - 10/2010
5	RivaroxabanIBA 01/2024 - 04/2016
5	apixabanIBA 01/2024 - 04/2016
5	Glycoproteins (Glycoprotein)IBA 02/2023 - 09/2013
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2018
5	Adenosine (Adenocard)FDA LinkGeneric 10/2020 - 08/2015
4	Trinitrotoluene (TNT)IBA 06/2022 - 01/2014
4	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2017
4	MicroRNAs (MicroRNA)IBA 04/2020 - 09/2013
4	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2016
4	LipidsIBA 01/2020 - 08/2010
4	Adenosine Diphosphate (ADP)IBA 04/2019 - 04/2010
4	cangrelorIBA 09/2016 - 09/2002
4	CreatinineIBA 09/2013 - 09/2010
3	dapagliflozinIBA 02/2024 - 12/2023
3	LigandsIBA 01/2023 - 05/2011
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
3	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 06/2008
3	EndotoxinsIBA 01/2021 - 12/2015
3	AR C124910XXIBA 05/2017 - 08/2015
2	Factor Xa InhibitorsIBA 05/2024 - 08/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 10/2019
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 05/2021
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023 - 01/2018
2	VaccinesIBA 01/2023 - 01/2022
2	N(2)-(3-trifluoromethylphenyl)guanineIBA 06/2022 - 07/2013
2	Enoxaparin (Lovenox)FDA LinkGeneric 05/2021 - 07/2018
2	Opiate AlkaloidsIBA 05/2021 - 07/2018

Therapy/Procedure

75	Therapeutics 01/2024 - 04/2009
50	Percutaneous Coronary Intervention 03/2024 - 06/2010
42	Stents 03/2024 - 11/2002
16	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2021 - 09/2009
12	Secondary Prevention 01/2021 - 12/2011
2	Drug-Eluting Stents 03/2024 - 01/2019
2	Conservative Treatment 08/2023 - 09/2017
2	Length of Stay 01/2022 - 01/2021
2	Duration of Therapy 06/2021 - 09/2015